DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/liv.15383
PubMed Identifier: 35924447
Publication URI: http://europepmc.org/abstract/MED/35924447
Type: Journal Article/Review
Volume: 43
Parent Publication: Liver international : official journal of the International Association for the Study of the Liver
Issue: 1
ISSN: 1478-3223